08:36 AM EDT, 10/29/2024 (MT Newswires) -- GeneDx Holdings ( WGS ) reported a Q3 net loss Tuesday of $0.31 per diluted share, narrowing from a loss of $1.64 a year earlier.

A sole analyst polled by Capital IQ expected a loss of $0.44.

Total revenue for the quarter ended Sept. 30 was $76.9 million, up from $53.3 million a year earlier.

Analysts surveyed by Capital IQ expected $65 million.

The company said it increased its fiscal 2024 revenue guidance to a range of $284 million to $290 million, from the previous outlook of $255 million to $265 million. Analysts surveyed by Capital IQ expect $263.4 million.

GeneDx ( WGS ) shares were up 14% in recent Tuesday premarket activity.

Price: 63.78, Change: +7.72, Percent Change: +13.77